✔️ Day 1, SOLACI-CACI 2021 ✔️ Andreas Gruentzig Auditorium 👨‍🏫 Program: 00:01 – Current Status of LATAM Cath Lab Nursing 01:33:19 – Coronary Structural Module – Valve Pathology 03:01:56 – Miscellaneous Processes in Hemodynamics 04:48:25 – Edwards Symposium – Overcoming challenges of the ballon expandable TAVI cases
✔️ TCT Session in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 02:44 – Future of TAVR – Martin B. Leon 36:27 – Future Developments in Trans-Catheter Mitral Valve Replacement – Juan F. Granada 01:02:53 – Interventional Heart Failure – Dan Burkhoff 👉🏻 Chairperson: Aníbal Damonte & Jorge Belardi 👉🏻 Digital Moderator: Matías Sztejman 👉🏻 Panelists:<a href="https://solaci.org/en/2021/09/14/solaci-caci-2021-tct-ii-session-structural-heart-interventions/" title="Read more" >...</a>
✔️ Watch again the Catheterization and Cardiovascular Interventions (CCI) Session in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 01:44 – The Hybrid Algorithm in Complex Chronic Total Occlusion Percutaneous Coronary Intervention: Experience of a Latin-American Centre – Héctor Hugo Escutia Cuevas 21:12 – SYNTAX score II application compared to GRACE score for prediction of Heart Failure<a href="https://solaci.org/en/2021/09/14/solaci-caci-2021-cci-session-2/" title="Read more" >...</a>
✔️ Watch again the complete SAC-FAC Session in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: – SESSION I: Functional Mitral Regurgitation: New Horizons for Transcatheter Therapy 01:06 – Optimal Medical Treatment in Patients with Cardiac Failure and Mitral Regurgitation – Florencia Renedo 12:12 – Ultrasonographic Screening of Patients for Endovascular Therapy – Walter García 25:43 –<a href="https://solaci.org/en/2021/09/14/solaci-caci-2021-sac-fac-session-2/" title="Read more" >...</a>
✔️ Watch the PICS-AICS session in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 02:07 – Initial Experience with Myvalve in Pulmonary Position – Carlos Pedra 17:54 – Mid-Term Follow-Up of Patients with Venus P Valve in LATAM – Francisco Garay 32:24 – New Insights in Tricuspid Valve Replacement – Raúl Arrieta 45:49 – Early Results with<a href="https://solaci.org/en/2021/09/14/solaci-caci-2021-pics-aics-session/" title="Read more" >...</a>
✔️ Watch the complete PCR in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 👉 How to manage Coronary Artery Disease in patients with Severe Aortic Stenosis eligible for TAVI? 04:51 – How does Coronary Artery Disease impact decision-making process of the Heart Team for patients with symptomatic severe AS? – Round Table Discussion 10:59 – ACTIVATION<a href="https://solaci.org/en/2021/09/14/solaci-caci-2021-europcr-session/" title="Read more" >...</a>
✔️ MICROPORT Symposium in the SOLACI-CACI 2021 Virtual congress.✔️ Topic: Leading with evidence, choosing with confidence. 👨‍🏫 Program: 00:05 – Opening & Welcome – Dr. José Mangione. 01:10 – MicroPort Company Introduction – William Krinickas. 10:05 – TARGET AC 4-year results from TARGET all comers trial – Dr. Alexandra Lansky. 29:43 – Four-year clinical outcomes<a href="https://solaci.org/en/2021/09/13/solaci-caci-2021-leading-with-evidence-choosing-with-confidence-microport-symposium/" title="Read more" >...</a>
✔️ Watch again the Edwards Lifesciences Symposium in the SOLACI-CACI 2021 Virtual Congress.✔️ Topic: Overcoming Challenges of the BALLOON EXPANDABLE TAVI Cases. 👨‍🏫 Program: 00:05 – Opening – Dr. José Mangione (BRA). 02:20 – Aortic VinV in small annuli: Does the final gradient matter? – Dr. Adolfo Ferrero (ARG). 21:14 – Small Annuli and<a href="https://solaci.org/en/2021/09/13/solaci-caci-2021-overcoming-challenges-of-the-balloon-expandable-tavi-cases-edwards-symposium-2/" title="Read more" >...</a>
The enthusiasm for direct oral anticoagulants after transcatheter aortic valve replacements (TAVR) is waning. At least, when it combines with atrial fibrillation. The ENVISAGE-TAVI AF has shown excessive bleeding with endoxaban vs. the classical vitamin K antagonists. Endoxaban resulted non-inferior to vitamin K antagonists in terms of net clinical adverse events, but major bleeding events<a href="https://solaci.org/en/2021/09/10/esc-2021-envisage-tavi-af-surprise-with-endoxaban-in-tavr-and-atrial-fibrillation/" title="Read more" >...</a>
Early intervention in asymptomatic valvular heart disease, age recommendations to decide between TAVR and surgery for aortic stenosis, and a push in favor of transcatheter repair in secondary mitral regurgitation are some of the new modifications to the European Society of Cardiology (ESC) Guidelines for the Management of Valvular Heart Disease. This new document was<a href="https://solaci.org/en/2021/09/09/esc-2021-updated-european-society-of-cardiology-guidelines-for-the-management-of-valvular-heart-disease/" title="Read more" >...</a>